Dernière mise à jour :
29/10/2024
Béta-bloquant   Propranolol hydrochloride  
Solution buvable
injectable
Stabilité des préparations Stabilité en mélange Facteur influençant la stabilité Compatibilités Bibliographie pdf
   Structure chimique  

Solution buvable
Bibliographie   Solution buvable   Bibliographie : Propranolol hydrochloride  
Type Source
2477 Revue Henry DW, Repta AJ, Smith FM, White SJ.
Stability of propranolol hydrochloride suspension compounded from tablets
Am J Hosp Pharm 1986 ; 43: 1492-1495.
2504 Revue Rooney M, Creurer I.
Stability of propranolol hydrochloride suspension and solution
Am J Hosp Pharm 1988 ; 45: 530-531.
2513 Revue Das Gupta V, Stewart KR.
Stability of propranolol hydrochloride suspension and solution compounded from injection or tablets
Am J Hosp Pharm 1987 ; 44: 360-361.
3356 Revue Geiger C M, Voudrie M A, Sorenson B.
Stability of Propranolol Hydrochloride in SyrSpend SF.
Int J Pharm Compound 2012 ; 16, 6 : 513-515.
3410 Revue Ensom M.H, Kendrick J, Rudolph S, Decarie D.
Stability of Propranolol in Extemporaneously Compounded Suspensions
Can J Hosp Pharm 2013 ; 66, 2: 118-124.
3996 Revue Dijkers E,Nanhekhan V,Thorissen A.
Updated Stability Data of Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSprend SF and Minoxidil in Espumil.
Int J Pharm Compound 2017 ; 21,3 : 240-241.
4177 Revue Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526

  Mentions Légales